Fresenius FY24 Results
Financial Results
Full Year 2024: Strong Fourth Quarter concludes successful Fiscal Year; Fresenius moving to next level of performance with #FutureFresenius Rejuvenate phase
FY/24: Upgraded outlook achieved, consistent financial performance with profitable growth.
- Group revenue1 at €21.5 billion with strong organic growth of 8%1,2
- Group EBIT1 at €2.5 billion, increase of 10%3 in constant currency; EBIT margin1 of 11.6%, 40 bps above prior year
- Net income1,4 grew by 13%3 in constant currency to €1,461 million, outpacing revenue growth
- EPS1,4 grew to €2.59
- Accumulative Group structural productivity savings ahead of plan reached €474 million (planned €400 million)
- Excellent Group operating cash flow of €2.4 billion resulting from focused cash management
- Deleveraging continued, net debt/EBITDA ratio further improved to 3.0x1,5 driven by excellent cash flow. Improvement of more than 70 bps since YE/23
- Dividend proposal of €1.00 per share
1 Before special items
2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation.
3 Growth rate adjusted for Argentina hyperinflation.
4 Excluding Fresenius Medical Care
5 At average exchange rates for both net debt and EBITDA; pro forma closed
acquisitions/divestitures, including lease liabilities, including Fresenius Medical Care
dividend
Selected Key Figures FY/2024
GROUP REVENUE 1
€ 21526 m
+ 8% 2
FY/23: €20,307 m
GROUP EBIT 1
€ 2489 m
+10% 3
FY/23: 2,266 m
NET INCOME 1, 4
€ 1461 m
+13% 3
FY/23: €1,300 m
EPS 1, 4
€ 2.59
+13% 3
FY/23: €2.31
1 Before special items
2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation
4 Excluding Fresenius Medical Care
Revenue by business segment
| € in millions | FY/24 | FY/23 | Growth at actual rates | Growth at constant rates | Organic growth1 | Acquisitions/Divestitures | % of total revenue |
|---|---|---|---|---|---|---|---|
Fresenius Kabi | 8,414 | 8,009 | 5% | 9% | 10%1 | -1% | 39% |
Fresenius Helios | 12,739 | 11,952 | 7% | 6% | 6% | 0% | 59% |
Total | 21,526 | 20,307 | 6% | 7% | 8% | -1% | 100%2 |
-
1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
2 Remaining 2% Corporate/Other revenue
Before special items